Schedule 13D ownership disclosure
Arcus Biosciences Inc
Common Stock, par value $0.0001 · CUSIP: 03969F109
Event date: 2025-02-18
- Filing-level shares
- 39,691,649
- Percent of class
- 35%
- GILEAD SCIENCES, INC.Reported CIK 0000882095
Shares: 39,691,649 · Class: 35%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001123292-25-000115
- Form type
- SCHEDULE 13D/A
- Filer
- Arcus Biosciences, Inc.
- CIK
- CIK 1724521
- Filed
- Mar 05, 2025
- Reporting period
- Feb 18, 2025
- Description
- Schedule 13D beneficial ownership